Annual EBITDA
-$51.57 M
-$40.35 M-359.69%
31 March 2024
Summary:
LakeShore Biopharma annual earnings before interest, taxes, depreciation & amortization is currently -$51.57 million, with the most recent change of -$40.35 million (-359.69%) on 31 March 2024. During the last 3 years, it has fallen by -$34.33 million (-199.18%). LSB annual EBITDA is now -392.96% below its all-time high of -$10.46 million, reached on 01 March 2022.LSB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$13.59 M
-$4.73 M-53.33%
30 September 2023
Summary:
LakeShore Biopharma quarterly earnings before interest, taxes, depreciation & amortization is currently -$13.59 million, with the most recent change of -$4.73 million (-53.33%) on 30 September 2023. LSB quarterly EBITDA is now -672.32% below its all-time high of $2.37 million, reached on 01 September 2022.LSB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$22.45 M
-$15.96 M-246.05%
30 September 2023
Summary:
LakeShore Biopharma TTM earnings before interest, taxes, depreciation & amortization is currently -$22.45 million, with the most recent change of -$15.96 million (-246.05%) on 30 September 2023. LSB TTM EBITDA is now -3731.03% below its all-time high of $618.20 thousand, reached on 01 September 2022.LSB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSB EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -359.7% | - | - |
| 3 y3 years | -199.2% | - | - |
| 5 y5 years | - | - | - |
LSB EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -393.0% | at low | -672.3% | at low | -3731.0% | at low |
| 5 y | 5 years | -393.0% | at low | -672.3% | at low | -3731.0% | at low |
| alltime | all time | -393.0% | at low | -672.3% | at low | -3731.0% | at low |
LakeShore Biopharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | -$51.57 M(+359.7%) | - | - |
| Sept 2023 | - | -$13.59 M(+53.3%) | -$22.45 M(+246.0%) |
| June 2023 | - | -$8.86 M(-473.3%) | -$6.49 M(-1149.3%) |
| Mar 2023 | -$11.22 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $2.37 M(-235.2%) | $618.20 K(-135.2%) |
| June 2022 | - | -$1.76 M | -$1.76 M |
| Mar 2022 | -$10.46 M(-39.3%) | - | - |
| Mar 2021 | -$17.24 M | - | - |
FAQ
- What is LakeShore Biopharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for LakeShore Biopharma?
- What is LakeShore Biopharma annual EBITDA year-on-year change?
- What is LakeShore Biopharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for LakeShore Biopharma?
- What is LakeShore Biopharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for LakeShore Biopharma?
What is LakeShore Biopharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of LSB is -$51.57 M
What is the all time high annual EBITDA for LakeShore Biopharma?
LakeShore Biopharma all-time high annual earnings before interest, taxes, depreciation & amortization is -$10.46 M
What is LakeShore Biopharma annual EBITDA year-on-year change?
Over the past year, LSB annual earnings before interest, taxes, depreciation & amortization has changed by -$40.35 M (-359.69%)
What is LakeShore Biopharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of LSB is -$13.59 M
What is the all time high quarterly EBITDA for LakeShore Biopharma?
LakeShore Biopharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is $2.37 M
What is LakeShore Biopharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of LSB is -$22.45 M
What is the all time high TTM EBITDA for LakeShore Biopharma?
LakeShore Biopharma all-time high TTM earnings before interest, taxes, depreciation & amortization is $618.20 K